Applied Therapeutics Inc (APLT) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket
 


Applied Therapeutics Inc   (NASDAQ: APLT)


Applied Therapeutics Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Applied Therapeutics Inc's ROI in the third quarter of 2025?
Applied Therapeutics Inc recorded a cumulative net loss of $-18 million during 12 months ending in the third quarter of 2025, resulting in a negative return on investment (ROI) of -62%.

Within the Healthcare sector 553 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 3470 to 3915.

Definition and Formula of Return on Investment



Return On Investment (Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Investment Change TTM -9.45 % 7.44 % 369.7 % - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1 20 39 57 6
Return On Investment (TTM) -62 % -223.13 % -99.89 % -208.55 % -579.78 %
APLT's Overall Ranking # 3915 # 3470 # 3162 # 4044 # 3482
Seq. Investment Change TTM -3.64 % -30.3 % -14 % 56.76 % 14.33 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -18 -68 -44 -106 -187




Return On Investment APLT's Ranking
Within: No.
Industry # 240
Sector # 554
Overall # 3915

Return On Investment Statistics
High Average Low
-31.71 %
-410.74 %
-3187.99 %
(Mar 31 2020)   (Jun 30 2023)







Financial Statements
Applied Therapeutics Inc's III. Quarter Investments $ 1 Millions APLT's Balance sheet
Applied Therapeutics Inc's III. Quarter Income $ -19 Millions Quarterly APLT's Income Statement
APLT's Income by Division See APLT's Income by Division


APLT Annual Return On Investment (Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
Total Investments in Millions 57 -16 5 63 82
Y / Y Investment Growth - - -92.1 % -23.68 % 151.29 %
Net Income in Millions -106 -120 -83 -106 -94
Y / Y Net Income Growth - - - - -
Annual Return On Investment -185.29 % - -1670.54 % -168.83 % -114.67 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
APLT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for APLT's Competitors
Subscribers only: Roi for Applied Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for APLT's Customers

Other Ratios
APLT's Roa APLT's Inventory Turnover Ratio APLT's Growth Rates APLT's Dividend Statistics
APLT's Profitability Ratios APLT's Asset Turnover Ratio APLT's Dividend Growth
APLT's Roe APLT's Valuation Ratios APLT's Financial Strength Ratios APLT's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI


Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.